S Vieths
Overview
Explore the profile of S Vieths including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
131
Citations
1838
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kallen E, Revers A, Fernandez-Rivas M, Asero R, Ballmer-Weber B, Barreales L, et al.
Allergy
. 2023 Jun;
78(9):2497-2509.
PMID: 37334557
Background: Pru p 3 and Pru p 7 have been implicated as risk factors for severe peach allergy. This study aimed to establish sensitization patterns to five peach components across...
2.
Steigerwald H, Krause M, Gonzalez-Menendez I, Quintanilla-Martinez L, Vieths S, Scheurer S, et al.
Sci Rep
. 2023 Feb;
13(1):1892.
PMID: 36732575
Peach allergy is among the most frequent food allergies in the Mediterranean area, often eliciting severe anaphylactic reactions in patients. Due to the risk of severe symptoms, studies in humans...
3.
Zimmer J, Schmidt S, Costanzo A, Buchheit K, Brown S, Carnes J, et al.
Pharmeur Bio Sci Notes
. 2022 Dec;
2022:55-86.
PMID: 36511317
Progress towards standardisation of allergen products has been made in recent years. Nevertheless, no standardised test method to quantify the allergen content of grass pollen allergen products is available at...
4.
Mahler V, Mentzer D, Bonertz A, Muraro A, Eigenmann P, Bousquet J, et al.
Clin Transl Allergy
. 2020 Jul;
10:28.
PMID: 32612805
Concerning development of medicinal products, children belong to a so-called "special population" for which additional legislation applies: Regulation (EC) No 1901/2006 on medicinal products for paediatric use sets up a...
5.
Bonertz A, Roberts G, Slater J, Bridgewater J, Rabin R, Hoefnagel M, et al.
Allergy
. 2017 Nov;
73(4):816-826.
PMID: 29150848
Adequate quality is essential for any medicinal product to be eligible for marketing. Quality includes verification of the identity, content and purity of a medicinal product in combination with a...
6.
Kaul S, Zimmer J, Dehus O, Constanzo A, Daas A, Buchheit K, et al.
Pharmeur Bio Sci Notes
. 2017 Nov;
2017:69-87.
PMID: 29143737
To date, the potency of allergen products in Europe is expressed in manufacturer-specific units relative to a product-specific in-house reference. Consequently, cross-product comparability of allergen products from different manufacturers with...
7.
Juesas C, Aguilar C, Vieths S
Allergol Immunopathol (Madr)
. 2017 Nov;
45 Suppl 1:39-40.
PMID: 29129404
No abstract available.
8.
Zimmer J, Bonertz A, Vieths S
Allergol Immunopathol (Madr)
. 2017 Nov;
45 Suppl 1:4-11.
PMID: 29128092
All allergen products for allergen immunotherapy currently marketed in the European Union are pharmaceutical preparations derived from allergen-containing source materials like pollens, mites and moulds. Especially this natural origin results...
9.
Datema M, Van Ree R, Asero R, Barreales L, Belohlavkova S, de Blay F, et al.
Allergy
. 2017 Oct;
73(3):549-559.
PMID: 28986984
Background: Component-resolved diagnosis (CRD) has revealed significant associations between IgE against individual allergens and severity of hazelnut allergy. Less attention has been given to combining them with clinical factors in...
10.
Pablos I, Eichhorn S, Machado Y, Briza P, Neunkirchner A, Jahn-Schmid B, et al.
Allergy
. 2017 Sep;
73(2):431-441.
PMID: 28960341
Background: Art v 1, Amb a 4, and Par h 1 are allergenic defensin-polyproline-linked proteins present in mugwort, ragweed, and feverfew pollen, respectively. We aimed to investigate the physicochemical and...